These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 21622646)

  • 1. Loss of p19Arf in a Rag1(-/-) B-cell precursor population initiates acute B-lymphoblastic leukemia.
    Hauer J; Mullighan C; Morillon E; Wang G; Bruneau J; Brousse N; Lelorc'h M; Romana S; Boudil A; Tiedau D; Kracker S; Bushmann FD; Borkhardt A; Fischer A; Hacein-Bey-Abina S; Cavazzana-Calvo M
    Blood; 2011 Jul; 118(3):544-53. PubMed ID: 21622646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD34+CD38+CD19+ as well as CD34+CD38-CD19+ cells are leukemia-initiating cells with self-renewal capacity in human B-precursor ALL.
    Kong Y; Yoshida S; Saito Y; Doi T; Nagatoshi Y; Fukata M; Saito N; Yang SM; Iwamoto C; Okamura J; Liu KY; Huang XJ; Lu DP; Shultz LD; Harada M; Ishikawa F
    Leukemia; 2008 Jun; 22(6):1207-13. PubMed ID: 18418410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RAG1 co-expression signature identifies ETV6-RUNX1-like B-cell precursor acute lymphoblastic leukemia in children.
    Chen D; Camponeschi A; Nordlund J; Marincevic-Zuniga Y; Abrahamsson J; Lönnerholm G; Fogelstrand L; Mårtensson IL
    Cancer Med; 2021 Jun; 10(12):3997-4003. PubMed ID: 33987955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel expression of cyclin-dependent kinase inhibitors in human B-cell precursors.
    Fink JR; LeBien TW
    Exp Hematol; 2001 Apr; 29(4):490-8. PubMed ID: 11301189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An instructive role for Interleukin-7 receptor α in the development of human B-cell precursor leukemia.
    Geron I; Savino AM; Fishman H; Tal N; Brown J; Turati VA; James C; Sarno J; Hameiri-Grossman M; Lee YN; Rein A; Maniriho H; Birger Y; Zemlyansky A; Muler I; Davis KL; Marcu-Malina V; Mattson N; Parnas O; Wagener R; Fischer U; Barata JT; Jamieson CHM; Müschen M; Chen CW; Borkhardt A; Kirsch IR; Nagler A; Enver T; Izraeli S
    Nat Commun; 2022 Feb; 13(1):659. PubMed ID: 35115489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenotypic alteration of bone marrow HSC and microenvironmental association in experimentally induced leukemia.
    Basak P; Chatterjee S; Das M; Das P; Pereira JA; Dutta RK; Chaklader M; Chaudhuri S; Law S
    Curr Stem Cell Res Ther; 2010 Dec; 5(4):379-86. PubMed ID: 20528754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemotherapy-induced niche perturbs hematopoietic reconstitution in B-cell acute lymphoblastic leukemia.
    Tang C; Li MH; Chen YL; Sun HY; Liu SL; Zheng WW; Zhang MY; Li H; Fu W; Zhang WJ; Liang AB; Tang ZH; Hong DL; Zhou BS; Duan CW
    J Exp Clin Cancer Res; 2018 Aug; 37(1):204. PubMed ID: 30157922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic regulation of the Ink4a-Arf (Cdkn2a) tumor suppressor locus in the initiation and progression of Notch1-driven T cell acute lymphoblastic leukemia.
    Volanakis EJ; Boothby MR; Sherr CJ
    Exp Hematol; 2013 Apr; 41(4):377-86. PubMed ID: 23178376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Constitutive Kit activity triggers B-cell acute lymphoblastic leukemia-like disease in mice.
    Weidemann RR; Behrendt R; Schoedel KB; Müller W; Roers A; Gerbaulet A
    Exp Hematol; 2017 Jan; 45():45-55.e6. PubMed ID: 27664314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High MN1 expression increases the in vitro clonogenic activity of primary mouse B-cells.
    Numata M; Yener MD; Ekmekçi SS; Aydın M; Grosveld G; Cardone M; Terranova S; Geltink RK; Özbek U; Özçelik E; Güleç Ç; Anak S; Karaman S; Öztürk G; Akbıyık M; Kandilci A
    Leuk Res; 2015 Aug; 39(8):906-12. PubMed ID: 26111797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Focal adhesion kinase is required for CXCL12-induced chemotactic and pro-adhesive responses in hematopoietic precursor cells.
    Glodek AM; Le Y; Dykxhoorn DM; Park SY; Mostoslavsky G; Mulligan R; Lieberman J; Beggs HE; Honczarenko M; Silberstein LE
    Leukemia; 2007 Aug; 21(8):1723-32. PubMed ID: 17568820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-risk acute lymphoblastic leukemia cells with bcr-abl and INK4A/ARF mutations retain susceptibility to alloreactive T cells.
    Young FM; Campbell A; Emo KL; Jansson J; Wang PY; Jordan CT; Mullen CA
    Biol Blood Marrow Transplant; 2008 Jun; 14(6):622-30. PubMed ID: 18489987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of AC133 and CD117 on candidate normal stem cell populations in childhood B-cell precursor acute lymphoblastic leukaemia.
    Baersch G; Baumann M; Ritter J; Jürgens H; Vormoor J
    Br J Haematol; 1999 Dec; 107(3):572-80. PubMed ID: 10583262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Flow cytometric detection of minimal residual disease in pre-cursor-B-acute lymphoblastic leukemia on the basis of phenotypic aberrancies on minor leukemic cell populations].
    Wu M; Sun XF; Xu ZM; Zhang XY; Li FR; Wang XG; Chen XL; Lin HQ; Wen HG; Sun X; Song TW
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Aug; 13(4):557-62. PubMed ID: 16129033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of the Polycomb-group gene rae28 causes maturation arrest at the early B-cell developmental stage.
    Tokimasa S; Ohta H; Sawada A; Matsuda Y; Kim JY; Nishiguchi S; Hara J; Takihara Y
    Exp Hematol; 2001 Jan; 29(1):93-103. PubMed ID: 11164110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcription from the RAG1 locus marks the earliest lymphocyte progenitors in bone marrow.
    Igarashi H; Gregory SC; Yokota T; Sakaguchi N; Kincade PW
    Immunity; 2002 Aug; 17(2):117-30. PubMed ID: 12196284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The transcriptional cofactor TRIM33 prevents apoptosis in B lymphoblastic leukemia by deactivating a single enhancer.
    Wang E; Kawaoka S; Roe JS; Shi J; Hohmann AF; Xu Y; Bhagwat AS; Suzuki Y; Kinney JB; Vakoc CR
    Elife; 2015 Apr; 4():e06377. PubMed ID: 25919951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ink4a and Arf are crucial factors in the determination of the cell of origin and the therapeutic sensitivity of Myc-induced mouse lymphoid tumor.
    Sugihara E; Shimizu T; Kojima K; Onishi N; Kai K; Ishizawa J; Nagata K; Hashimoto N; Honda H; Kanno M; Miwa M; Okada S; Andreeff M; Saya H
    Oncogene; 2012 Jun; 31(23):2849-61. PubMed ID: 21986948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aberrant ZNF423 impedes B cell differentiation and is linked to adverse outcome of ETV6-RUNX1 negative B precursor acute lymphoblastic leukemia.
    Harder L; Eschenburg G; Zech A; Kriebitzsch N; Otto B; Streichert T; Behlich AS; Dierck K; Klingler B; Hansen A; Stanulla M; Zimmermann M; Kremmer E; Stocking C; Horstmann MA
    J Exp Med; 2013 Oct; 210(11):2289-304. PubMed ID: 24081948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical value of RAG1 expression and IKZF1 deletions in Philadelphia negative pediatric B cell precursor acute lymphoblastic leukemia.
    Aref S; Khaled N; Menshawy NE; Sabry M; Agder MA
    Pediatr Hematol Oncol; 2020 Aug; 37(5):380-389. PubMed ID: 32644850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.